In Vitro Antifungal Activity of Nikkomycin Z in Combination with Fluconazole or Itraconazole
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Nikkomycins are nucleoside-peptide antibiotics produced by Streptomyces species with antifungal activities through the inhibition of chitin synthesis. We investigated the antifungal activities of nikkomycin Z alone and in combination with fluconazole and itraconazole. Checkerboard synergy studies were carried out by a macrobroth dilution procedure with RPMI 1640 medium at pH 6.0. At least 10 strains of the following fungi were tested: Candida albicans , other Candida spp., Cryptococcus neoformans , Coccidioides immitis , Aspergillus spp., and dematiacious fungi (including Exophiala jeanselmei , Exophiala spinifera , Bipolaris spicifera , Wangiella dermatitidis , Ochroconis humicola , Phaeoannellomyces werneckii , and Cladophialophora bantiana ), and 2 strains each of Fusarium , Scedosporium , Paecilomyces , Penicillium , and Trichoderma spp. A total of 110 isolates were examined. Inocula of fungal elements were standardized by hemacytometer counting or spectrophotometrically. MICs and minimum lethal concentrations (MLCs) were determined visually by comparison of growth in drug-treated tubes with growth in drug-free control tubes. Additive and synergistic interactions between nikkomycin and either fluconazole or itraconazole were observed against C. albicans , Candida parapsilosis , Cryptococcus neoformans , and Coccidioides immitis . Marked synergism was also observed between nikkomycin and itraconazole against Aspergillus fumigatus and Aspergillus flavus . No antagonistic interaction between the drugs was observed with any of the strains tested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antifungal susceptibility testing
Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A., & Galgiani, J. N. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.367 · Cited by 361
Self-citationCompounds active against cell walls of medically important fungi
Hector, R. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.1 · Cited by 242 · cited 1×
“albicans are moderately susceptible (6, 15), other Candida species are resistant to nikkomycin Z in vitro (14).”
BackgroundHector, R. F., Zimmer, B. L., & Pappagianis, D. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.4.587 · Cited by 189 · cited 3×
“In an animal model, nikkomycin Z was reported to prolong the survival of mice infected with Coccidioides immitis and Blastomyces dermatitidis (17).”
BackgroundCell Envelope of Candida Albicans
Shepherd, M. G. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104445 · Cited by 137 · cited 1×
“Chitin and glucans are major components of the fungal cell wall and play important roles in maintaining the structural integrity of fungal cells (13, 26).”
Background
Cited by
Infections Caused by Scedosporium spp
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., et al. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-07 · Cited by 786
Self-citationMelanized Fungi in Human Disease
Revankar, S. G., & Sutton, D. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-10 · Cited by 569
Sharp, R. (2013) · Agronomy · doi:10.3390/agronomy3040757 · Cited by 403
Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*
Guarro, J., Kantarcioglu, A. S., Horré, R., Luis Rodriguez-Tudela, J., Cuenca Estrella, M., Berenguer, J., & Sybren De Hoog, G. (2006) · Medical Mycology · doi:10.1080/13693780600752507 · Cited by 297
Fungal cell membrane-promising drug target for antifungal therapy
Sant, D. G., Tupe, S. G., Ramana, C. V., & Deshpande, M. V. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13301 · Cited by 245
“Nikkomycin Z, a chitin synthase inhibitor in combination with fluconazole or itraconazole was tested in vitro for the synergistic antifungal action against different pathogens (Li and Rinaldi 1999).”
BackgroundFungal Cell Wall: Emerging Antifungals and Drug Resistance.
Lima, S. L., Colombo, A. L., & de Almeida Junior, J. N. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02573 · Cited by 223
“(1990); Lamoth and Alexander (2015); Li and Rinaldi (1999); Nakai et al.”
BackgroundReview of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
Steinbach, W. J., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/376523 · Cited by 161
“tibiotics on bacteria cell walls, leading to osmotic lysis [28].”
BackgroundHasim, S., & Coleman, J. J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0465 · Cited by 144
“, and other opportunistic fungi have been reported to be resistant to nikkomycins perhaps due to their degradation and difficulty to penetrate the cell membrane [91,94,95].”
BackgroundSurvival in the Presence of Antifungals
Meyer, V., Damveld, R. A., Arentshorst, M., Stahl, U., van den Hondel, C. A. M. J. J., & Ram, A. F. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705856200 · Cited by 85
Pianalto, K. M., Billmyre, R. B., Telzrow, C. L., & Alspaugh, J. A. (2019) · Genetics · doi:10.1534/genetics.119.302290 · Cited by 41
Hartland, K., Pu, J., Palmer, M., Dandapani, S., Moquist, P. N., Munoz, B., DiDone, L., Schreiber, S. L., & Krysan, D. J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00111 · Cited by 24
Metadata
- Authors
- Li, R. K., & Rinaldi, M. G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-06
- Volume
- 43
- Issue
- 6
- Pages
- 1401-1405
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2114703336
- Cited by
- 129
- References
- 4
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.